The influence of dose differences of remifentanil to functions of endocrine system in perioperative patients

The influence of dose differences of remifentanil to functions of endocrine system in perioperative patients - The influence of dose differences of remifentanil to functions of endocrine system in perioperative patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013606

Enrollment

Registered

2014-04-02

Start date

2014-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative adult patients undergoing orthopedic surgery

Interventions

Remifentanil 1 microgram/kg/min Remifentanil 0.5 microgram/kg/min Remifentanil 0.25 microgram/kg/min

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Perioperative adult patients undergoing total hip arthroplasty(THA)

Exclusion criteria

Exclusion criteria: Patients with preoperative heart failure, severe valvular disease, not sinus rhythm and obesity(BMI>=30)

Design outcomes

Primary

Measure	Time frame
renin, aldosterone, cortisol	—

Countries

Japan

Contacts

Public ContactTakerou Terashi

Kagoshima Red Cross Hospital Department of anesthesiology

terashi@m2.kufm.kagoshima-u.ac.jp099-261-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026